Kratom faces scrutiny over health risks

Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we take a look at the year that was in…

The cinnamon, which originated from a plant in Ecuador, had lead levels more than 2,000 times higher than a maximum level proposed by the FDA, officials said.

CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle to boost profits.  The closures will begin in February and finish by the end of April, the spokesperson said in a statement. She added that employees affected by the…

Although U.S. consumers buy products on the assumption that they are safe, potentially dangerous items often make it past regulators and into retailers. In 2023, the year began and ended with recalls and warnings involving products that can be deadly for children. Here’s a look at some products recalled last year that consumers should be…

Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…

The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…